drug protocol number

GBT2104-132

drug sponsor

Global Blood Therapeutics (GBT)

drug study

Inclacumab

drug trial site

Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabi

drug status

Completed

drug phase